Endolymphatic Hydrops Tied to Hearing Loss Severity in Meniere Disease

Follow Drugslib on

Medically reviewed by Drugs.com.

By Elana Gotkine HealthDay Reporter

WEDNESDAY, Oct. 2, 2024 -- For patients with bilateral Meniere disease (MD), features of endolymphatic hydrops correlate with the severity of hearing loss and staging of MD, according to a study published online Sept. 16 in Head & Face Medicine.

Xu Liu, M.D., from Fudan University in Shanghai, and colleagues conducted a retrospective analysis involving 77 patients diagnosed with bilateral MD. Endolymphatic hydrops features in the affected ear were assessed through gadolinium-enhanced inner ear magnetic resonance imaging.

The researchers identified a significant correlation between the degree of endolymphatic hydrops and hearing loss across all frequencies, including the cochlear, vestibular, and overall degree of endolymphatic hydrops. The correlation between the overall degree of endolymphatic hydrops and hearing loss was strongest at low frequencies, followed by middle and high frequencies (r = 0.571, 0.508, and 0.351, respectively), with a correlation of r = 0.463 for MD staging. Within the same patient, more severe hearing loss and MD staging was exhibited in affected ears with endolymphatic hydrops in the cochlea and vestibule compared with ears with isolated endolymphatic hydrops.

"The findings of this research into the correlation between the characteristics of endolymphatic hydrops and hearing loss in bilateral MD contribute to an enhanced comprehension of the syndrome, particularly by focusing on the distinct clinical features of bilateral MD," the authors write.

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2024-10-03 12:00

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords